HISTRELIN Drug Record

  • HISTRELIN chembl:CHEMBL1201255 ApprovedAntineoplastic

    Alternate Names:

    ORF 17070RWJ 17070
    RWJ-17070
    SUPPRELIN
    HISTRELIN
    ORF-17070
    5-OXO-L-PROLYL-L-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TYROSYL-N(TAU)-BENZYL-D-HISTIDYL-L-LEUCYL-L-ARGINYL-N-ETHYL-L-PROLINAMIDE
    RWJ 17070
    ORF 17070
    L-PYROGLUTAMYL-L-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TYROSYL-D-N(IM)-BENZYL-HISTIDYL-L-LEUCYL-L-ARGINYL-L-PROLINE ETHYLAMIDE
    VANTAS®
    [(IM-BZL)-D-HIS(6),PRO(9)-NET]-GONADOTROPIN RELEASING HORMONE
    chembl:CHEMBL1201255
    chemidplus:76712-82-8
    pubchem.compound:25077993
    rxcui:50975

    Drug Info:

    FDA Approval approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • HISTRELIN   GNRHR2

    Interaction Score: 3.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name VP 002, histrelin implant,Vantas, Supprelin
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • HISTRELIN   GNRHR

    Interaction Score: 1.03

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name VP 002, histrelin implant,Vantas, Supprelin
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial